Freeline Therapeutics Holdings plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2022 to Q1 2023.
  • Freeline Therapeutics Holdings plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2023 was 65.1M shares, a 52.7% increase year-over-year.
  • Freeline Therapeutics Holdings plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 59.3M shares, a 66% increase from 2021.
  • Freeline Therapeutics Holdings plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 35.7M shares, a 152% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 65.1M +22.5M +52.7% Jan 1, 2023 Mar 31, 2023 6-K 2023-05-30
Q1 2022 42.6M Jan 1, 2022 Mar 31, 2022 6-K 2023-05-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.